Comparison on Blood Pressure Effect of an Equivalent Sodium Intake, With Different Nature, for Hypertensive Subjects
NCT05108402 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2021-11-04
Summary
Numerous large-scale epidemiological studies have made it possible to establish a link between the average consumption of table salt (sodium chloride) and blood pressure figures. In France, according to the French Agency for Food, Environmental and Occupational Health \& Safety (ANSES), salt intakes could be estimated from 2 national food consumption surveys INCA 1 and INCA 2. This made it possible to take a photograph of food consumption habits and to show that the average consumption of salt contained in food in France is 8.7g/day for men and 6.7g/day for women. To these contributions must also be added 1 to 2g of salt for the resalting and the cooking water. According to the food consumption survey INCA 3, french plate still contains a large part of processed foods and still a little too much salt (on average 9g/day for men and 7g/day for women at compare with the objectives of the National Health Nutrition Program of 8g/day and 6.5g/day respectively). In addition, the World Health Organization (WHO) recommends consuming less than 5g of salt per day.
In this context, sodium intake through mineral water was also questioned. Both in terms of basic and clinical research, the biological effects of dietary sodium chloride intake have been the subject of a great deal of work for several decades. The mechanisms of transmission in the induced or hemodynamic effects related to the absorption of Na multiple debates and their impact on cardiovascular risks remain very uncertain. Work has shown that all subjects do not react homogeneously to sodium chloride intakes, thus determining what are called "NaCl-sensitive" people who in a situation of major sodium intake will show an increase of peripheral vascular resistance and an increase in blood pressure, much more marked than in subjects called " NaCl resistant ".
"NaCl-sensitive" people represent 10 to 30% of the population, with notable differences according to ethnic origins, regions and continents. A marked overrepresentation of this phenotype is observed in patients with hypertension or with a family history of hypertension.
Furthermore, studies conducted on animals and humans show that sodium intake does not have the same impact on the parameters mentioned above, depending on whether it is in the form of chloride or bicarbonate salt.
On the basis of these elements, the investigators developed a clinical study protocol intended to demonstrate a possible differential effect in the biological effects of the same sodium orally intake (2.56g per day), depending on the salt origin.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Phenotyping
After inclusion in the study, between V1 and V4, patients will be phenotyped among: "NaCl sensitive" patients and "non-NaCl sensitive" patients. they will have a low sodium diet for 2 weeks. The first week without salt supplementation and the second with salt supplementation. At the end of V4, if patient is "NaCl sensitive" he will continue into treatment period and go through randomization, and for patient "non-NaCl sensitive" they will drop out of study.
- DIETARY_SUPPLEMENT
-
Drug intake
After being phenotyped, "NaCl sensitive" patients will continue the study in one of the 2 treatments arms : royal water (bottle) or salt sachet.
Sponsors & Collaborators
-
University Hospital, Clermont-Ferrand
lead OTHER
Principal Investigators
-
Gisele PICKERING, MD · Platform of Clinical Investigation/Clinical Investigation Center French Institute of Health and Medical Research-1405 63000 Clermont-Ferrand FRANCE
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-31
- Primary Completion
- 2023-01-31
- Completion
- 2024-01-31
Countries
- France
Study Locations
More Related Trials
-
Human Sodium Balance Study
NCT04110262 ·Status: COMPLETED ·Phase: NA
-
TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA
NCT04677322 ·Status: TERMINATED
-
Effect of Dietary Sodium Intake on Blood Pressure in Hypertensive Patients in Primary Care
NCT01334138 ·Status: COMPLETED ·Phase: NA
-
The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults
NCT04074941 ·Status: COMPLETED ·Phase: NA
-
Blood Pressure Response to Sodium in the Diet
NCT01899495 ·Status: UNKNOWN ·Phase: NA
-
Dietary Salt Intake and Vascular Function
NCT00590512 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
NCT03558022 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Response to Salt in Essential Hypertension
NCT01665534 ·Status: COMPLETED ·Phase: PHASE3
-
Adverse Neurogenic Actions of Dietary Salt
NCT02881515 ·Status: COMPLETED ·Phase: NA
-
CARDIA-Salt Sensitivity of Blood Pressure (SSBP)
NCT04258332 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
NCT01566084 ·Status: COMPLETED ·Phase: NA
-
Effects of Salt Intake on the Nervous Systems of Patients With Salt-Sensitive High Blood Pressure
NCT00001176 ·Status: COMPLETED
-
The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function
NCT01575041 ·Status: COMPLETED ·Phase: NA
-
Genetic Determinant of Blood Pressure Sensitivity to Salt Intake
NCT01706887 ·Status: TERMINATED ·Phase: NA
-
Increased Salt Sensitivity of Ambulatory Blood Pressure in Women With a History of Severe Preeclampsia
NCT01874990 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Refractory Hypertension (High and Low Salt Diet)
NCT02357017 ·Status: WITHDRAWN ·Phase: NA
-
Hypertension Prevention Trial (HPT) Feasibility Study
NCT00000501 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Potassium Salts on Blood Pressure and Target Organ Damage
NCT00160368 ·Status: UNKNOWN ·Phase: PHASE3
-
Salt and Gut Study
NCT04958148 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects
NCT02527837 ·Status: UNKNOWN ·Phase: PHASE1
-
The Significance of Sodium Balance and the Value of Salt-blood Test in Identifying Salt Sensitive Patients
NCT05165823 ·Status: COMPLETED ·Phase: NA
-
Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure
NCT03424993 ·Status: COMPLETED ·Phase: PHASE4
-
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
NCT01074918 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Salt and HMB Study
NCT05515900 ·Status: UNKNOWN ·Phase: NA
-
Salt Study: Inhibited Breathing Pattern and Sodium Inhibitors in Sodium Sensitivity of Blood Pressure
NCT00800228 ·Status: COMPLETED